Undertreatment, Treatment Trends, and Treatment Dissatisfaction Among Patients With Psoriasis and Psoriatic Arthritis in the United States

Abstract

Psoriasis is a chronic, inflammatory skin condition that is associated with significant morbidity.¹ The direct and indirect costs of psoriasis are estimated at $11 billion annually in the United States.² Patients with severe psoriasis often experience decrements in health-related quality of life similar to those with depression, diabetes mellitus, and congestive heart failure.³ In addition to the physical and functional impairments from their joint destruction, patients with psoriatic arthritis experience significant decrements in other aspects of activities of daily living, decreased quality of life, and loss of work productivity.⁴